Lenvatinib for RAI-Refractory DTC: A Multidisciplinary View with Dr. Newbold
Автор: THANC Foundation
Загружено: 2025-12-19
Просмотров: 207
We are proud to have Dr. Kate Newbold present, "Use of Lenvatinib in the Treatment of Radioiodine-refractory Differentiated Thyroid Cancer: A Multidisciplinary Perspective for Daily Practice." Discussion with Dr. Alan Ho.
0:00 Webinar
2:51 Dr. Newbold presents
40:17 Dr. Ho presents
53:26 Discussion with Q&A
#TIROxMDS #ThyroidCancer #DifferentiatedThyroidCancer #RAIRefractory #Lenvatinib #TargetedTherapy #EndocrineOncology #ThyroidOncology #CancerPharmacology #MultidisciplinaryCare #MedicalEducation #OncologyWebinar**
Check out our other programs! **
The THANC Guide
https://thancguide.org/
TIRO: Thyroid Int'l Recommendations Online
https://tiro.expert/
** Follow us on Twitter! **
@thancfoundation - https://shorturl.at/puwS0
THANC on FB - https://shorturl.at/svNY4
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
